FASS; Deborah

Patent Applications and Registrations

Patent applications and USPTO patent grants for FASS; Deborah.The latest application filed is for "chimeric quiescin sulfhydryl oxidase (qsox1) antibodies and uses of same".

Company Profile

2.4.10

FASS; Deborah - Rehovot IL
Fass; Deborah - Cambridge MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Chimeric Quiescin Sulfhydryl Oxidase (qsox1) Antibodies And Uses Of Same App 20210292437 - FASS; Deborah ; et al.	2021-09-23
Antibodies Targeting Quiescin Sulfhydryl Oxidase (qsox1) And Uses Of Same App 20210147575 - FASS; Deborah ; et al.	2021-05-20
Antibodies targeting quiescin sulfhydryl oxidase (QSOX1) and uses of same Grant 10,829,561 - Fass , et al. November 10, 2	2020-11-10
Antibodies Targeting Quiescin Sulfhydryl Oxidase (qsox1) And Uses Of Same App 20180273639 - FASS; Deborah ; et al.	2018-09-27
Qsox1 As An Anti-neoplastic Drug Target App 20180185477 - LAKE; Douglas ; et al.	2018-07-05
Compositions For Inhibition Of Quiescin Sulfhydryl Oxidase (qsox1) And Uses Of Same App 20170247468 - FASS; Deborah ; et al.	2017-08-31
Qsox1 As An Anti-neoplastic Drug Target App 20170182158 - LAKE; Douglas ; et al.	2017-06-29
Compositions for inhibition of quiescin sulfhydryl oxidase (QSOX1) and uses of same Grant 9,631,028 - Fass , et al. April 25, 2	2017-04-25
Qsox1 As An Anti-neoplastic Drug Target App 20160122765 - LAKE; Douglas ; et al.	2016-05-05
Compositions For Inhibition Of Quiescin Sulfhydryl Oxidase (qsox1) And Uses Of Same App 20150110786 - Fass; Deborah ; et al.	2015-04-23
Core structure of gp41 from the HIV envelope glycoprotein Grant 7,402,396 - Chan , et al. July 22, 2	2008-07-22
Core structure of gp41 from the HIV envelope glycoprotein App 20050053917 - Chan, David C. ; et al.	2005-03-10
Core structure of GP41 from the HIV envelope glycoprotein App 20030099935 - Chan, David C. ; et al.	2003-05-29
Core structure of gp41 from the HIV envelope glycoprotein Grant 6,150,088 - Chan , et al. November 21, 2	2000-11-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.